AbbVie halts late-stage trial for lung cancer drug Rova-T

AbbVie Inc said on Wednesday it had halted enrollment for a late stage trial of Rova-T as a second-line therapy for advanced small-cell lung cancer, following recommendations made by an independent data monitoring committee.

Asian longhorned tick spreading in U.S

(Reuters Health) – – The Asian longhorned tick has spread across nine states since it first appeared in the U.S. last year, according to a report from the Centers for Disease Control and Prevention (CDC).

Smartphone app could screen for anemia

(Reuters Health) – – For people with chronic anemia who want to monitor their condition or those who just suspect they might be anemic, a fast answer could soon come from a smartphone selfie – of their fingernails, researchers say.

Pre-race screening of runners could reduce life-threatening health issues

(Reuters Health) – – As long-distance races like half-marathons and full marathons become more popular, race organizers and medical directors should consider using online medical screening to identify risky runners and avert medical emergencies, researchers say.

Showing people their own arteries might improve heart health

(Reuters Health) – – People who see vivid pictures of their own arteries getting clogged up with debris may be more likely to adopt a heart-healthy lifestyle than individuals who don’t see these images, a recent experiment suggests.